Tech Company Financing Transactions
Eclipse Therapeutics Funding Round
Eclipse Therapeutics secured a $2.8 million venture capital round on 10/17/2011. Investors included private investors.
Transaction Overview
Company Name
Announced On
10/17/2011
Transaction Type
Debt
Amount
$2,775,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
11575 Sorrento Valley Road 203
San Diego , CA 92121
USA
San Diego , CA 92121
USA
Phone
Website
Email Address
Overview
Eclipse Therapeutics, Inc. is a private biotechnology company dedicated to the discovery and development of therapeutics that target cancer stem cells and other forms of innovative cancer treatment. Cancer stem cells are a subset of cells within a tumor thought to play a critical role in tumor initiation, metastasis and recurrence.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jonathan Lim
Chief Scientific Officer
Chris Reyes
President
Peter Chu
Browse more venture capital transactions:
Prev: 10/17/2011: Clickable venture capital transaction
Next: 10/18/2011: Topica Pharmaceuticals venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on tech company VC transactions. VC transactions on this site are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs